Raghu Rao's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 20,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics | Raghu Rao | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 20,000 | 22,356 | - | - | Common Stock | |
| Sonnet BioTherapeutics | Raghu Rao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 373 | 2,356 | - | - | Common Stock | |
| Sonnet BioTherapeutics | Raghu Rao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 3,770 | 26,140 | - | - | Common Stock |